Anthony R. Chase, Director at Sarepta Therapeutics, Inc. (SRPT), sold 33,000 shares at $13.95 ($477K) on 2012-09-07, disclosed to the SEC on 2012-09-11.
Open-market sale of $477k SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.95 | 13,300 | $186K | 38.9% |
| 2 | $14.79 | 19,700 | $291K | 61.1% |
| Total | $14.45 avg | 33,000 | $477K | 100% |
| Filing → |
| LYB | BUY | 2023-07-10 | $3K | — | Filing → |
| APC | BUY | 2017-05-18 | $200K | — | Filing → |
| APC | BUY | 2014-09-02 | $189K | — | Filing → |